NCT03846427 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 68
- units
- Participants
- groups
- description
- Zanubrutinib 160 mg (two 80-mg capsules) orally twice daily with or without food until progressive disease, intolerable toxicity, or withdrawal of consent
- id
- BG000
- title
- Zanubrutinib
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 11.41
- value
- 67.9
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 32
- title
- Female
- measurements
- group Id
- BG000
- value
- 36
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 58
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 10
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 13
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 40
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- Multiple
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Other
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Unknown
- categories
- measurements
- group Id
- BG000
- value
- 11
- title
- Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 68
- units
- Participants
- groups
- description
- Zanubrutinib 160 mg (two 80-mg capsules) orally twice daily with or without food until progressive disease, intolerable toxicity, or withdrawal of consent
- id
- BG000
- title
- Zanubrutinib
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 11.41
- value
- 67.9
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 32
- title
- Female
- measurements
- group Id
- BG000
- value
- 36
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 58
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 10
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- BG000
- value
- 13
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 40
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- Multiple
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Other
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Unknown
- categories
- measurements
- group Id
- BG000
- value
- 11
- title
- Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle